AARTIDRUGS437.00

Aarti Drugs Ltd.

· Pharma & Health
₹ CrorePeersALIVUSAARTIPHARMADVENZYMESAGARWALEYEAKUMSAPLLTDCORONAHCGMcap ₹3,988 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation51.555.867.0
+ Unrealised FX (Gain) / Loss-1.80.3-0.5
Changes in Working Capital
+ Inventories34.313.0-17.9
+ Trade Receivables — Current161.134.4-70.0
+ Other Financial Assets — Non-current0.3-0.3-0.0
+ Other Non-current Assets0.01.20.0
+ Trade Payables — Current-92.5-43.723.6
+ Provisions — Current1.93.73.7
Cash from Operating Activities
Profit Before Tax (per I/S)235.5211.8210.9229.0
+ Total Adjustments (incl. Working Capital)154.664.35.9
Cash from Operations (pre-tax)390.1276.1216.8
+ Interest Received — Operating-2.5-12.2-1.2
+ Interest Paid — Operating-33.5-35.9-33.7
+ Dividends Received — Operating0.0-0.00.0
+ Other Inflows / (Outflows) — Operating0.2-0.00.1
+ Income Taxes Paid62.455.1-4.1
Cash from Operating Activities358.9244.6253.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)226.3177.2173.3
+ Disp of Fixed Assets0.20.10.3
+ Disp of Investment Property0.00.30.0
+ Purchase of Investments (Equity / Debt)0.00.01.6
+ Dividends Received — Investing0.00.00.0
+ Interest Received — Investing2.512.21.2
+ Other Inflows / (Outflows) — Investing0.00.0-0.0
Cash from Investing Activities-223.7-164.6-173.4
Cash from Financing Activities
+ Buyback / Redemption of Own Shares0.073.20.0
+ Proceeds from Borrowings148.2111.243.0
+ Repayment of Borrowings45.977.670.0
+ Interest Paid31.333.432.3
+ Dividends Paid9.39.118.2
+ Other Inflows / (Outflows) — Financing-197.70.00.0
Cash from Financing Activities-136.0-82.1-77.4
Net Changes in Cash (pre-FX)-0.8-2.22.7
Net Changes in Cash-0.8-2.22.7
Closing Cash6.7
Reference Items
EBITDA316.5287.1309.2333.3
EBITDA Margin %12.5212.0312.0512.45
Free Cash Flow (CFO − Capex)132.667.480.280.2
Free Cash Flow to Equity83.810.5
Free Cash Flow per Basic Share14.537.398.798.79
Price to Free Cash Flow49.72
Cash Flow to Net Income2.091.451.30
Cash Paid for Taxes62.455.1-4.1
Cash Paid for Interest31.333.432.3
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.